Business Context and Reporting Period
This Form 8-K is a current report filed by Capricor Therapeutics, Inc. on March 10, 2014. The filing serves as a Regulation FD disclosure regarding an upcoming investor presentation by the Company's Chief Executive Officer, Dr. Linda Marbán.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is informational and does not contain financial statements or performance data.
Material Changes
No material changes to financial condition or operations are reported in this document. The filing solely announces a scheduled corporate event.
Guidance, Outlook, and Management Commentary
- Event: Dr. Linda Marbán, CEO, is scheduled to present at the 26th Annual ROTH Conference.
- Date and Time: March 10, 2014, at approximately 4:00 p.m. Pacific time.
- Location: The Ritz Carlton in Dana Point, California.
- Access: A webcast of the presentation is available on the "Investors" section of the Company's website (www.capricor.com).
- Materials: Presentation slides are available on the website and will be archived for at least 30 days.
Key Facts for Investor Verification
- Verify the availability of the webcast and presentation slides on the Capricor Therapeutics investor relations website.
- Confirm the specific date and time of the ROTH Conference presentation to ensure timely access.
- Note that the information in this 8-K is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.